menu search

1 under-the-radar stock that could triple by 2030

Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two...

November 4, 2023, 7:30 am

Eli lilly beats on q3 earnings: etfs to buy

Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-...

November 3, 2023, 12:47 pm

Should you still buy the nasdaq's best-performing october stocks?

Structure Therapeutics' weight-loss drug candidate is attracting attention over excitement about obesity...

November 3, 2023, 5:20 am

Portillo's ceo shuts down obesity drug impact speculation

Portillo's (PTLO) released its' third-quarter earnings revealing mixed results. Adjusted earnings per share of 7 cents was in line with expectations, ...

November 2, 2023, 3:27 pm

Weight loss drug wegovy sales fuel novo nordisk stock performance

Novo Nordisk (NVO) stock rose after the pharmaceutical company reported strong third-quarter sales growth, fueled by its popular weight-loss drug, Weg...

November 2, 2023, 2:58 pm

Novo nordisk, eli lilly stocks see boost on obesity drugs

Novo Nordisk (NVO) shares rose as the drugmaker's third-quarter profits jumped 56% year-over-year, fueled by surging demand for its ...

November 2, 2023, 11:26 am

Novo nordisk: obesity drugs priority over century-old focus on insulin

Novo Nordisk said on Thursday treating obesity with its weight-loss drug Wegovy as a precursor to type ...

November 2, 2023, 6:38 am

Novo nordisk shares higher on bumper wegovy boost

Shares in Europe's largest drugs company rose 1.6% in early trade boosted by the performance of its breakthrough weight loss drug Wegovy. Novo Nordisk...

November 2, 2023, 4:17 am

Amgen's obesity drug plans, outlook for 2024

Amgen (AMGN) reported third-quarter earnings that beat expectations and raised its full-year revenue guidance. The company recently completed its acqu...

October 31, 2023, 3:41 pm

Weight-loss drugs in spotlight as pharma services firms rush to snap up business

Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmac...

October 27, 2023, 2:07 am

Altimmune to present new data on the anti-inflammatory and anti-fibrotic properties of pemvidutide in a late-breaking presentation at the liver meeting® 2023

GAITHERSBURG, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that n...

October 25, 2023, 7:30 am

Novo nordisk milks the obesity cash cow - how long will it last?

NVO's obesity/diabetes drug, Wegovy/Ozempic, is projected to outperform the best-selling drug of all ti...

October 24, 2023, 9:30 am

Novo nordisk: growing to potentially become the first trillion-dollar european champion

Novo Nordisk stock has tripled since 2020 and is up over 30% YTD; but there is still upside. Novo is poised to benefit from the surging demand for dia...

October 24, 2023, 1:24 am

Wall street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — a look at the numbers

Citi notched its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That view seems conservative....

October 23, 2023, 3:47 pm

Disruptive tech theme of the week: weight loss revolution

According to the latest CDC National Diabetes Statistics Report, more than 37 million people have diabetes in the U.S., or 11.3% of the population. Th...

October 23, 2023, 3:02 pm

Eli lilly is waiting for obesity-drug approval. here's how much it could be worth.

Eli Lilly's diabetes drug Mounjaro is expected to be approved to treat obesity in the near future. It c...

October 23, 2023, 8:19 am

The $100 billion dollar opportunity in obesity drugs, goldman sachs analyst explains

A Goldman Sachs report predicts that the total addressable market for weight loss drugs could reach $100 billion dollars by 2030. Popular weight loss ...

October 21, 2023, 8:00 am

Eli lilly planning diabetes drug trial for children six years and older: report

Eli Lilly and Co (NYSE:LLY) is planning a trial of its diabetes drug Mounjaro in patients with obesity ...

October 20, 2023, 1:01 pm

Eli lilly plans diabetes drug trial for kids as young as 6 years - bloomberg

Eli Lilly is planning a clinical trial of its diabetes drug Mounjaro in patients six years and older who have ...

October 20, 2023, 6:35 am


Search within

Pages Search Results: